With a stellar track record across leading pharmaceutical companies, Chouraqui is poised to guide Pharming Group’s strategic transformation. Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) has announced the nomination of Fabrice Chouraqui as its next Chief Executive Officer and Executive Director. Chouraqui is set to succeed Sijmen de Vries, marking a pivotal leadership change for the global biopharmaceutical company. His formal appointment will be proposed at an upcoming Extraordinary General Meeting of Shareholders (EGM), with further details forthcoming. De Vries, who has played a critical role in Pharming’s development, will step down from the Board of Directors upon Chouraqui’s appointment. … Continue reading Pharming Group Nominates Fabrice Chouraqui as CEO to Lead the Next Phase of Growth